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A simple and accurate reversed phase high-performance liquid chromatography coupled with diode array detector (HPLC-DAD)
method for simultaneously determining and quantifying the antioxidants carotenes, xanthophylls, and retinol in human plasma is
presented in this paper. Compounds were extracted with hexane, a C30 column, and a mobile phase of methanol, methyl tert-butyl
ether, and water were used for the separation of the compounds. A total of 8 carotenoids, 3 Z-𝛽-carotene isomers, and 1 fat-soluble
vitamin (retinol) were resolved within 72min at a flow rate of 0.6mL/min. Detection was achieved at 450 nm for carotenoids and
330 nm for retinol. To evaluate the effectiveness of themethod, it has been applied to an intervention study conducted on eight
volunteers. Results. Limits of detection were between 0.1 𝜇g/mL for lycopene and astaxanthin and 1.3𝜇g/mL for 15-Z-𝛽-carotene.
Recoveries were ranged between 89% and 113% for 𝛼-carotene and astaxanthin, respectively. Accuracy was between 90.7% and
112.2% and precision was between 1% and 15% RSD. In human plasma samples compounds studied were identified besides three
lycopene isomers, demonstrated to be suitable for application in dietary intervention studies. Conclusions. Due to its accuracy,
precision, selectivity, and reproducibility, this method is suitable to dietary habits and/or antioxidants status studies.
1. Introduction
Several epidemiologic studies have shown that oxidative
stress plays an essential role in the pathogenesis of many
degenerative diseases, such as cancer, diabetes, age-related
eye diseases, and cardiovascular diseases [1–6] and it has
been suggested that antioxidants may exert a protective role
against these chronic diseases by defending against oxidative
damage [7, 8]. There is an increasing interest in the analysis
of carotenoids and some fat-soluble vitamins such as retinol
(vitaminA) due to their antioxidant properties and their rela-
tionship with the prevention of chronic diseases [9–12]. The
characterization and quantification of carotenoids and retinol
in human plasma are essential for best interpretation of epi-
demiologic studies linking oxidative stress, diet, and health.
Carotenoids comprise a group of fat soluble phytochem-
icals widely distributed in nature, responsible for the colours
ofmany fruits and vegetables, as well as certain animal tissues
and leaf coloration after the degradation of chlorophyll [13].
Considering the number of double bonds in the molecules,
carotenoids can be found with cis or trans configuration (or
E/Z isomers). In general the all-E form is predominant in
nature but numerous researches show that more than 50% of
some carotenoids, as lycopene, present in human plasma and
tissues are Z-isomers [14] and it is believed that geometrical
configuration of carotenoids could have implications in the
solubility, absorption, and transport in humans [15, 16] or
even geometrical isomers of provitamin A carotenoids have
different vitamin A activities [17]. The enhanced absorption
of lycopene Z-isomers is hypothesised to result from higher
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solubility in mixed micelles, the shorter length of the Z-
isomers, and/or a lower tendency to aggregate [14, 18]. This
hypothesis was supported by studies in both animals and
humans [18, 19].
Among fat-soluble vitamins, retinol exerts an important
antioxidant action via the inhibition of lipid peroxidation and
has free-radical-scavenging properties [11, 20]; meanwhile,
carotenoids are known to be effective quenchers of singlet
oxygen, as well as strong scavengers of different reactive
oxygen species (ROS) [21].
High-performance liquid chromatography (HPLC) is
one of the most used techniques for the identification of
carotenoids [22, 23] as well as vitamin A in human plasma
[24–26]. The advantages of the use of this technique are
speed, sensitivity, and accuracy for the determination of
the compounds in addition to the economy of the solvents
required and the simple coupling with other techniques.
In light of the importance of these compounds for health
maintenance, an accurate determination and quantification
in plasma is necessary. The aim of this study is to develop a
simple HPLC method to identify the main carotenoids and
their geometrical isomers as well as retinol, one of the major
antioxidant fat-soluble vitamins, in human plasma.
2. Experimental Procedures
2.1. Materials and Methods
2.1.1. Reagents and Standards. Carotenoids and vitamins
standards: retinol, astaxanthin, lutein, zeaxanthin, E-𝛽-apo-
8󸀠-carotenal, cryptoxanthin, 15-Z-𝛽-carotene, 13-Z-𝛽-caro-
tene, 𝛼-carotene, 𝛽-carotene, 9-Z-𝛽-carotene, and lycopene
were purchased from Sigma-Aldrich (St. Louis, MO, USA).
Methanol (MeOH) and methyl-tert-butyl ether (MTBE)
of HPLC grade were obtained from Panreac Quimica SA
(Barcelona, Spain). Ultrapure water (Milli-Q) was generated
by a Millipore System (Bedford, MA, USA). Human plasma
and butylated hydroxytoluene (BHT) were acquired from
Sigma-Aldrich.
2.1.2. Preparation of Standard and Stock Solutions. Individual
working standards of retinol, astaxanthin, lutein, zeaxanthin,
E-𝛽-apo-8󸀠-carotenal, cryptoxanthin, 15-Z-𝛽-carotene, 13-
Z-𝛽-carotene, 𝛼-carotene, 𝛽-carotene, 9-Z-𝛽-carotene, and
lycopene were prepared at a concentration of 1mg/mL
in MTBE. All working standards were manipulated under
protection of light to minimise light-induced isomerisation,
stored in eppendorf tubes, and kept at −20∘C until use.
The stock solution used to spike plasma samples was
prepared by mixing individual working standards at a con-
centration of 50mg/mL in MTBE.
2.1.3. Extraction and Isolation of Carotenoids and Retinol.
Plasma was subjected to a liquid-liquid extraction procedure
previously described by our working group [27]. Briefly,
800 𝜇L of plasma was mixed with 800 𝜇L of ethanol and 2mL
of hexane/BHT (100mg/L). Then, 300𝜇L of stock solution
was added followed by a vortex-mixing for 1 minute and
centrifuged at 2062 gr for 5 minutes at 4∘C. The upper
nonpolar layer was removed and the remaining aqueous
plasma mixture was reextracted as described above. The two
nonpolar extracts were combined in a glass vial and dried
under nitrogen gas at<25∘C followed by a reconstitutionwith
300 𝜇L of MTBE. Then, the samples were stored into insert-
amber vials for HPLC at −20∘C until the day of analysis.
2.1.4. Instrumentation. Chromatographic analysis was car-
ried out in anHP 1100HPLC system (Hewlett-Packard,Wald-
bronn, Germany), consisting of a quaternary pump and an
autosampler coupled to a diode array detector DAD G1315B.
Chromatographic separation was performed on a reversed-
phase column YMC Carotenoid S-5 𝜇m, 250mm × 4.6mm
(Waters, Milford,MA), maintained at 25∘C, and connected to
a precolumn YMCGuard Cartridge Carotenoid 20 × 4.0mm
i.d, S-5 𝜇m. The guard column was replaced every 500 injec-
tions. The integration was performed with Agilent Chem-
Station Software. The DAD detector was adjusted at 450 nm
for the carotenoids and 330 nm for retinol, respectively. All
compounds were identified by retention time compared with
pure standards as well as by the UV-Vis spectra of each
compound.
2.1.5. Chromatographic Conditions. The chromatographic
separation was performed using the following solvents:Milli-
Q water (A), methanol (B), and MTBE (C). Solvent A was
used isocratically at 4% while the following linear gradient
was used for B (𝑡 (min), %B): (0.0, 90); (40.0, 40); (60.0,
6); (62.0, 90); (72.0, 90). Twenty microliter aliquots of the
samples were injected in the HPLC-DAD system. Total run
time was 72 minutes at a flow rate of 0.6mL/min.
2.1.6. Quality Parameters. The method was fully validated
based on the criteria of the AOAC International and the
U.S. Department of Health and Human Services Food and
Drug Administration (FDA) [28, 29].The quality parameters
established for the validation of the method were accuracy,
intra- and interday precision, recovery, limit of detection
(LoD), limit of quantification (LoQ), and linearity.
Three dilutions were prepared from the stock solution in
MTBE to the final concentrations of low (1.5𝜇g/mL),medium
(4 𝜇g/mL), and high (9 𝜇g/mL) for all analytes for precision
and accuracy assays.
Accuracy consisted in the closeness of agreement
between the measured value and the reference value and was
established by repetitively spiking blank plasma with three
known concentrations of analyte standards: low, medium,
and high with respect to the calibration curves, in five
replicates. The results were determined as the percentage of
the ratio of the mean observed concentration and the known
spiked concentration in the biological matrices. The mean
value should be within ±15% of the nominal value.
Intraday precision and interday precision were consid-
ered using five determinations per three concentration levels:
low, medium, and high in a single analytical run or in three
different days, respectively. The precision of the method
was assessed on the % RSD (percentage of relative standard
deviation) of intra- and interday repeatability and the values
determined at each concentration level should not exceed
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15% of RSD, according to the regulation of the AOAC and
FDA.
Recovery was accomplished by preparing seven-point
calibration curves and seven-point external curves, spiked
before and after extraction, respectively. The detector
response obtained from the amount of analyte added to and
extracted from the biological matrix was compared to the
detector response obtained for the same concentration of
the pure authentic standard. A linear regression between
the ratio analyte concentration against the calculated
concentration has been applied, and the slope multiplied by
100 corresponded to the analyte recovery.
Limit of detection (LoD) and limit of quantification
(LoQ)were determined by comparingmeasured signals from
samples with the low concentration of analyte with those of
blank samples and establishing the minimum concentration
at which the analyte can be reliably detected or quantified. A
signal-to-noise ratio in the order of 3 : 1 and 10 : 1, for LoD and
LoQ, respectively, was considered acceptable.
Linearity was tested by assessing signal responses of
target analytes from plasma samples spiked in duplicate at
seven different concentrations and by calculation of linear
regression.
2.2. Method Application: Pilot Dietary Intervention Study
2.2.1. Biological Material. To assess the efficiency in the
identification of carotenoids and retinol in human plasma,
the present method was applied to a small-scale prospective,
open and controlled, single-arm intervention study con-
ducted in eight volunteers free of cardiovascular disease but
with high risk of developing it, aged 69.9 ± 3.8 years with a
mean body mass index of 32.3 ± 3.8 kg/m2.
The volunteers were instructed to avoid the consumption
of tomato and tomato-based products 3 days before the study.
On the experimental day, after 12 hours of fasting, blood
samples were collected early in the morning to quantify
carotenoids and retinol as baseline. After that, all volunteers
have followed a similar diet developed by a trained dietitian,
which took into account their preferences and tastes, as well
as the consideration that participants were diabetic, obese,
hypertensive, and/or dyslipidemic. Each day during 4 weeks,
participants consumed 250mL of tomato juice before dinner
and at the end of the study blood samples were taken for
comparing with baseline. All samples were stored at −80∘C
until analysis.
The study protocol was approved by the Ethics Commit-
tee of Clinical Investigation of the University of Barcelona
(Spain), and the clinical trial was registered at the Inter-
national Standard Randomized Controlled Trial Number
(ISRCTN20409295).Written informed consent was obtained
from all participants.
2.3. Statistical Analysis. Statistical analysis was performed
using the SPSS Statistical Analysis System (version 22.0; SPSS
Inc, Chicago, IL). Data are presented as means and stan-
dard deviation (SD). Statistical differences between the two
interventions were analysed by the nonparametric statistical
Wilcoxon test for paired comparisons. Statistical significance
was set at 𝑝 < 0.05.
3. Results and Discussion
3.1. HPLC Method Development
3.1.1. Extraction. For the extraction of carotenoids and
retinol, precipitation of proteins from plasma as a prior step
is required. To achieve this issue, most methods use organic
solvents such as methanol, ethanol, or acetonitrile [30].
Some studies use ethanol-BHT at different concentrations
[31, 32]while others use ethanol-ascorbic acid [33] or ethanol-
saline [34] for protection of carotenoids besides deproteiniza-
tion. Different solvents and solvent combinations have been
described in the literature for removing lipophilic analytes
from biosamples. Hexane alone [35, 36] or combined with
other solvents, such as hexane/acetone [37], hexane/ether
[34], or hexane/ethanol/acetone/toluene [38], seems to be
the most used solvents for the extraction of carotenoids and
lipophilic compounds from plasma. There are few studies
where hexane-BHT is used for protection of carotenoids dur-
ing the extraction [39, 40] while other authors prefer to use
hexane-saline [34]. Both mixtures, hexane-BHT and hexane-
saline, were tested for extraction. Recoveries obtained with
hexane-saline were between 57.4% and 86.9% correspond-
ing to E-lycopene and 13-Z-𝛽-carotene, respectively, versus
recoveries range between 73.4% and 90.4% corresponding
to E-lycopene and 𝛽-carotene, respectively, using hexane-
BHT as extraction solvent. Due to its simplicity, speed,
and good recoveries achieved, ethanol for deproteinization
and repeated extraction with hexane-BHT were chosen for
performing this study.
3.1.2. Separation and Identification. Numerous HPLC
methods are reported for separation and identification of
carotenoids and fat-soluble vitamins from diverse complex
matrices such as food, food products, or plasma. The use of
isocratic or gradient systems coupled to different types of
columns and/or coupled to different detectors or even the
use of different temperatures for the stability of the analytes,
depending of the compounds studied is the best described
technique for these purposes.
Reversed-phase HPLC with C
18
columns and isocratic or
gradient elution seems to be the modality most commonly
used for identification and quantification of carotenoids and
fat-soluble vitamins [41–44]. One of the major problems in
the identification of carotenoids and lipophilic compounds
using C
18
columns seems to be the separation of geometrical
isomers of carotenoids [41–47]. Tzeng et al. [33] have devel-
oped an isocratic method for the identification of carotenoids
using a C
18
column, but they could only separate three
carotenoids: lutein, lycopene, and 𝛽-carotene. Olmedilla et al.
[40] also have described a gradientmethodwith aC
18
column
but could not identify isomers of the carotenoids. To solve this
issue, polymeric C
30
columns were developed for separation
of Z-E isomers [22, 48, 49].The use of this kind of column has
allowed us the separation of the twelve compounds studied,
including 3 Z-isomers of 𝛽-carotene and another 3 Z-isomers
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Figure 1: Representative HPLC chromatogram of carotenoids and retinol standards in MTBE.
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Figure 2: Representative HPLC chromatogram of carotenoids and retinol in human plasma corresponding to a volunteer after tomato juice
intervention.
of lycopene. Figures 1 and 2 show a representative HPLC-
DAD chromatogram of carotenoids and retinol in a standard
mixture and a human plasma sample, respectively.
Likewise lutein and zeaxanthin are reported as two
difficult compounds to separate on monomeric C
18
columns
[42, 43]. Gueguen et al. [44] found an inadequate resolution
of lutein and zeaxanthin with the method proposed using a
C
18
column and an isocratic elution system; Thibeault et al.
[31] were not able to differentiate lutein and zeaxanthin with
these same conditions. A high resolution can be achieved by
using polymeric C
30
columns with gradient elution [22, 49,
50]. With the present method, all analytes, including lutein
and zeaxanthin, have reached a resolution higher than 1.5,
indicating a good separation of the compounds and a good
symmetry of all peaks. Results are shown in Table 1.
Coupling of photodiode array detector (DAD) and fluo-
rescence detector (FLD) is the technique chosen by Epler et
al. [51] and Liu et al. [32] for identification of carotenoids and
retinols from human serum and foods. Using more complex
techniques, such as photoisomerization of some analytes as a
prior step, Ferruzzi et al. [49] identified 13 lycopene isomers
(Z/E) by using an electrochemical detector (ECD). Lyan
et al. [46] and Lee et al. [47, 52] have identified various
carotenoids by the coupling of two different detectors or
columns. Other authors like Gleize et al. [53] have set up a
gradient method for the identification of eleven carotenoids
and fat-soluble vitamins from complex matrixes such as food
samples, human plasma, and human adipose tissue using a
single C
30
column kept at 35∘C. All these techniques allow
the separation and identification of lipid compounds such as
carotenoids and fat soluble vitamins from different matrices
but are complex and require coupling of columns and use of
temperature or combination of detectors, which is not always
possible in all laboratories.
In this study, carotenoids and retinol were separated in
a single run on a reversed-phase column using a gradient
system of water, methanol, and MTBE. The mobile phase
was optimized in order to obtain the best separation of the
compounds in the shortest time possible and to achieve this,
several gradients were assessed. The best results obtained
for the conditions were described in the chromatographic
conditions section.
3.2. Validation Parameters
3.2.1. Linearity. According to the maximal reported value
in plasma for each analyte, plasma samples were spiked in
duplicate at seven different concentrations ranged from LoQ
of each compound to 10 𝜇g/mL.The analytical procedure was
linear over the concentration range testedwith the correlation
coefficient from0.9952 to 0.9984 for all compounds in plasma
samples, demonstrating a good linearity of the curves. Table 4
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Table 1: Resolution of the analytes studied.
Analyte Rt(min)
Wavelength
(nm)
Width
(min) Resolution
Retinol 8.54 330 0.6 N.d.
Astaxanthin 34.07 450 0.38 2.3
Lutein 36.55 450 0.72 1.4
Zeaxanthin 38.24 450 0.53 2.2
E-𝛽-apo-8󸀠-carotenal 40.01 450 0.29 7.7
Cryptoxanthin 43.94 450 0.22 6.9
15-Z-𝛽-carotene 46.96 450 0.22 1.4
13-Z-𝛽-carotene 47.57 450 0.21 1.3
𝛼-carotene 48.12 450 0.2 2.9
𝛽-carotene 49.57 450 0.31 2.3
9-Z-𝛽-carotene 50.76 450 0.2 33.0
E-lycopene 64.29 450 0.21 33.0
N.d.: not determined.
𝑅 = 2[(Rt)𝐵 − (Rt)𝐴]/(𝑊𝐴 +𝑊𝐵).
𝑅 = resolution.
Rt = retention time.
𝑊 = width.
summarizes the correlation coefficients of the curves of all
compounds.
3.2.2. Accuracy and Precision. Accuracy and intra and inter-
day precision were studied. All compounds analysed met
the acceptance criteria to not overcome 15% RSD in both
intra- and interday precision and in the three concentration
levels. The highest values were 15% belonging to astaxanthin,
zeaxanthin, 𝛼-carotene, 𝛽-carotene, and 13-Z-𝛽-carotene.
Accuracy results obtained were between 90.7% and 112.2%
being within limits of accuracy, 85–115%. The method pro-
posed demonstrated good accuracy and precision in plasma
samples, asserting that was feasible for the determination
of carotenoids and retinol in human plasma. Results are
expressed in Tables 2 and 3.
3.2.3. Recovery. Recovery for retinol was 96%, similar to
the value achieved by Kand’a´r et al. [54]. For carotenoids,
the recoveries were between 89% and 113%, corresponding
to 𝛼-carotene and astaxanthin, respectively. Comparing our
results with those reported by Talwar et al. [43] we achieved
a recovery 18% higher for lutein and 9% higher for 𝛽-
carotenewith the describedmethod; comparingwith the data
presented by Tzeng et al. [33], we achieved a better recovery
for lutein (20% higher), and comparing with Rajendran et al.
[22] we obtained a better recovery for lutein (19% higher),
zeaxanthin (13% higher), and cryptoxanthin (7% higher).
Karppi et al. [39] have reported similar values of recovery
except for lutein, zeaxanthin, and 𝛽-carotene that were 10%,
17%, and 16%, respectively, lower than in the present study.
The extraction procedure was really effective, since high
recoveries can be observed in Table 2.
3.2.4. Limit of Detection (LoD) and Limit of Quantification
(LoQ). The LoD found was 0.1 𝜇g/mL for astaxanthin and
Table 2: Accuracy and recovery of the compounds studied.
Analyte Accuracy (%) Recoveries (%)
Retinol 105 ± 9 96 ± 3
Astaxanthin 99 ± 7 113 ± 6
Lutein 99 ± 13 112 ± 9
Zeaxanthin 101 ± 11 107 ± 5
E-𝛽-apo-8󸀠-carotenal 98 ± 10 94 ± 3
Cryptoxanthin 103 ± 12 96 ± 3
15-Z-𝛽-carotene 90 ± 13 101 ± 2
13-Z-𝛽-carotene 105 ± 12 92 ± 5
𝛼-carotene 98 ± 12 89 ± 4
𝛽-carotene 97 ± 13 96 ± 2
9-Z-𝛽-carotene 112 ± 7 93 ± 3
E-lycopene 100 ± 12 91 ± 3
lycopene; 0.2𝜇g/mL for retinol, zeaxanthin, E-𝛽-apo-8󸀠-
carotenal, cryptoxanthin, 𝛽-carotene, and 9-Z-𝛽-carotene;
0.4 𝜇g/mL for lutein and 13-Z-𝛽-carotene; 0.5 𝜇g/mL for 𝛼-
carotene, and 1.3 𝜇g/mL for 15-Z-𝛽-carotene. The LoQ was
from 0.3 𝜇g/mL to 4.4 𝜇g/mL for astaxanthin and 15-Z-𝛽-
carotene, respectively. All LoD and LoQ values obtained are
expressed in Table 4. In a study carried out by Mitrowska et
al. [55] similar valueswere obtained forE-𝛽-apo-8󸀠-carotenal,
astaxanthin, and lycopene. In another study developed by
Talwar et al. [43] a similar value for retinol but not for the
other compounds studied can be observed; nonetheless, with
the presented method we have achieved the separation and
identification of 11 carotenoids and 1 fat-soluble vitamin in a
single run.
3.2.5. Plasma Levels of Carotenoids and Retinol. The method
was used for measuring concentrations of carotenoids and
retinol in human plasma samples. All compounds were
determined following the procedure described above and the
results are expressed in Table 5.
Nine of the 12 validated analytes were identified in plasma
at baseline: retinol, astaxanthin, lutein, E-𝛽-apo-8󸀠-carotenal,
cryptoxanthin, 13-Z-𝛽-carotene, 𝛼-carotene, 𝛽-carotene, and
lycopene. It is important to highlight that, besides the iden-
tification of the validated compounds, we also have searched
for cis isomers of lycopene which have been suggested to be
more bioavailable than E-lycopene, typically found in raw
food [18]. In fact, in human plasma, total lycopene is an
isomeric mixture containing 40% to 50% as Z-isomers [5]
and according to the antioxidant properties of lycopene, from
greatest to least are 5-Z, 9-Z, 7-Z, 13-Z, 15-Z, 11-Z, and all-E
lycopene [56].Wehave identified 5-Z, 9-Z, and 13-Z lycopene,
all present in human plasma according to the study carried
out by Arranz et al. [27]
After tomato juice intervention, an increase in retinol,
astaxanthin, cryptoxanthin, 13-Z-𝛽-carotene, 𝛽-carotene, 13-
Z-lycopene, 9-Z-lycopene,E-lycopene, and 5-Z-lycopenewas
observed, with values between 5.194 and 0.140 𝜇g/mL cor-
responding to E-lycopene and 13-Z-𝛽-carotene, respectively.
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Table 4: Limit of detection (LoD), limit of quantification (LoQ), range of concentration, calibration curve, and correlation coefficient of the
analytes in blank plasma spiked with standard solution.
Analytes LoD (𝜇g/mL) LoQ (𝜇g/mL) Linearity range (𝜇g/mL) Calibration curve Correlation coefficient (𝑟)
Retinol 0.2 0.7 0.7–10 𝑦 = 69.684𝑥 − 15.857 0.9952
Astaxanthin 0.1 0.3 0.3–10 𝑦 = 49.138𝑥 + 3.0197 0.9964
Lutein 0.4 1.3 1.3–10 𝑦 = 119.37𝑥 − 2.263 0.9954
Zeaxanthin 0.2 0.7 0.7–10 𝑦 = 69.14𝑥 + 1.53 0.9955
Apo-8󸀠-carotenal 0.2 0.7 0.7–10 𝑦 = 249.4𝑥 − 20.908 0.9957
Cryptoxanthin 0.2 0.7 0.7–10 𝑦 = 200.48𝑥 − 15.759 0.9952
15-Z-𝛽-carotene 1.3 4.3 4.3–10 𝑦 = 91.235𝑥 − 10.848 0.9984
13-Z-𝛽-carotene 0.4 1.3 1.3–10 𝑦 = 90.591𝑥 + 8.7376 0.9969
𝛼-carotene 0.5 1.6 1.6–10 𝑦 = 243.07𝑥 − 37.135 0.9966
𝛽-carotene 0.2 0.7 0.7–10 𝑦 = 105.8𝑥 − 2.9437 0.9983
9-Z-𝛽-carotene 0.2 0.7 0.7–10 𝑦 = 75.685𝑥 − 8.4189 0.9959
E-lycopene 0.1 0.3 0.3–10 𝑦 = 34.532𝑥 − 4.2861 0.9952
Table 5: Carotenoids and retinol in human plasma before (baseline) and after the dietary intervention.
Analytes
Concentration
Baseline After intervention Baseline After intervention
Mean ± SD (𝜇g/mL) Mean ± SD (𝜇g/mL) Mean ± SD (𝜇mol/L) Mean ± SD (𝜇mol/L)
Retinol 1.82 ± 0.37 1.90 ± 0.49 3.46 ± 0.70 3.62 ± 0.93
Astaxanthin 0.76 ± 0.44 0.88 ± 0.37 1.27 ± 0.74 1.48 ± 0.63
Lutein 0.07 ± 0.02 0.06 ± 0.06 0.13 ± 0.03 0.11 ± 0.11
Zeaxanthin N.d. N.d. N.d. N.d.
E-𝛽-apo-8󸀠-carotenal 0.57 ± 0.03 0.57 ± 0.03 1.38 ± 0.06 1.38 ± 0.08
Cryptoxanthin 0.18 ± 0.12 0.20 ± 0.07 0.32 ± 0.22 0.37 ± 0.12
15-Z-𝛽-carotene N.d. N.d. N.d. N.d.
13-Z-𝛽-carotene 0.13 ± 0.00 0.14 ± 0.02 0.23 ± 0.00 0.26 ± 0.04
𝛼-carotene 0.22 ± 0.00 N.d. 0.41 ± 0.00 N.d.
𝛽-carotene 0.95 ± 0.50 1.09 ± 0.53 1.77 ± 0.93 2.03 ± 0.98
9-Z-𝛽-carotene N.d. N.d. N.d. N.d.
13-Z-lycopene N.d.a 2.79 ± 1.44a N.d.a 5.20 ± 2.69a
9-Z-lycopene N.d.a 0.38 ± 1.42a N.d.a 0.71 ± 2.64a
E-lycopene 1.15 ± 0.83a 5.19 ± 2.35a 2.14 ± 1.54a 9.67 ± 4.38a
5-Z-lycopene 0.75 ± 1.10a 3.07 ± 1.43a 1.41 ± 2.06a 5.72 ± 2.67a
N.d.: not determined.
SD: standard deviation.
aValues in a row with the same letter are significantly different (𝑝 < 0.05). Data analyzed by Wilcoxon test for repeated measures.
Among these compounds, lycopene and its isomers have pre-
sented a significant increase after tomato juice consumption
(𝑝 < 0.05). Results are shown in Table 5.
In a study carried out by Pellegrini et al. [57], they found
a concentration of 0.31 𝜇g/mL of lycopene and 0.17 𝜇g/mL of
𝛽-carotene in human plasma after a consumption of tomato
pure´e. In another study performed by Porrini et al. [58],
they have seen values in the order of 0.18, 0.21, 0.02, 0.13,
0.03, and 0.23 𝜇g/mL for lycopene, lutein, zeaxanthin, 𝛽-
cryptoxanthin, 𝛼-carotene, and 𝛽-carotene, respectively, after
a daily supplementation of tomato pure´e. Ga¨rtner et al. [59]
have determined values of 0.02, 0.0002, and 0.001 𝜇g/mL for
lycopene, 𝛼-carotene, and 𝛽-carotene, respectively, after a
consumption of tomato paste. Regarding retinol, the results
obtained with the present method are higher than those
reported by Liu et al. [32] who have found a mean of
0.55 𝜇g/mL and 0.56 𝜇g/mL in plasma of women and men,
respectively, participants of the Toronto Nutrigenomics and
Health Study.
4. Conclusions
Based on previous reported work, the present method is
simple, accurate, reliable, sensitive, and selective for the
determination of the antioxidants carotenoids and retinol in
human plasma samples. With this method, all analytes of
interest were successfully resolved, including lutein, zeax-
anthin, and Z-isomers of 𝛽-carotene which have previously
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been reported as critical compounds to identify and separate.
The sample preparation procedure in this method provides
excellent recoveries for all analytes.
A total of 8 carotenoids, 3 Z-isomers of the 𝛽-carotene, 1
fat-soluble vitamin, and also 3Z-isomers of the lycopenewere
simultaneously separated and identified in human plasma
by the use of polymeric C
30
chromatography column with a
gradient elution.
Future approaches to enhance the analysis of the isomers
should focus on the conclusive identification of the com-
pounds that remain tentatively identified. For this purpose,
the isolation of standards of most cis-isomers and the deter-
mination of their absorption coefficients are needed for their
accurate quantification.
The HPLC method was completely validated and due to
the good results obtained after the intake of tomato juice,
this method may be applied to evaluate the liposoluble
antioxidants carotenoids and vitamin A in clinical interven-
tion antioxidants trials and epidemiological studies status
investigations.
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